VXRT

Vaxart Stock Price

7.825
0.795 (11.31%)
Upgrade to Real-Time
Regular Market
7.825
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.795 11.31% 7.825 12:31:13
Open Price Low Price High Price Close Price Previous Close
7.34 7.31 8.17 7.03
Bid Price Ask Price Spread News
7.82 7.83 0.01 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
57,333 16,562,925 $ 7.76 $ 128,476,319 11,311,150 0.2805 - 17.49
Last Trade Time Type Quantity Stock Price Currency
12:31:14 50 $ 7.8267 USD

Vaxart Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 847.90M 109.47M 83.54M $ 9.86M $ - -0.79 -58.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Vaxart News

Date Time Source News Article
11/19/202011:35Edgar (US Regulatory)Current Report Filing (8-k)
11/12/202016:15Edgar (US Regulatory)Quarterly Report (10-q)
11/12/202016:03Edgar (US Regulatory)Current Report Filing (8-k)
10/14/202006:05Edgar (US Regulatory)Current Report Filing (8-k)
10/13/202017:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/08/202015:41Edgar (US Regulatory)Current Report Filing (8-k)
10/07/202008:02PR Newswire (US)Centaur Biopharmaceutical Services Announces Expansion of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.618.176.016.7210,521,7361.2218.38%
1 Month5.028.173.505.2613,420,6902.8155.88%
3 Months5.5459.433.506.7518,450,4632.2841.12%
6 Months2.693117.492.108.6121,860,6845.13190.56%
1 Year0.354517.490.28056.7915,228,1347.472,107.33%
3 Years7.46917.490.25436.605,488,7080.3564.77%
5 Years20.3525.080.25436.653,352,947-12.53-61.55%

Vaxart Description

Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus.
Your Recent History
NASDAQ
VXRT
Vaxart
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 17:46:15